Design Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DSGN and other ETFs, options, and stocks.About DSGN
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease.
DSGN Key Statistics
Stock Snapshot
Design Therapeutics(DSGN) stock is priced at $15.99, giving the company a market capitalization of 977.45M. It carries a P/E multiple of -13.10.
On 2026-07-05, Design Therapeutics(DSGN) stock moved within a range of $14.22 to $16.94. With shares now at $15.99, the stock is trading +12.4% above its intraday low and -5.6% below the session's peak.
Trading volume for Design Therapeutics(DSGN) stock has reached 1.58M, versus its average volume of 1.24M.
The stock's 52-week range extends from a low of $3.52 to a high of $17.25.
The stock's 52-week range extends from a low of $3.52 to a high of $17.25.
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.